Results 111 to 120 of about 63,047 (307)
Background Treatment of central nervous system relapse in adult acute lymphoblastic leukemia is a challenge and outcome is poor. Liposomal cytarabine has a prolonged half-life and, given intrathecally, has produced high response rates in patients with ...
Nicola Gökbuget +19 more
doaj +1 more source
Primary Dural Lymphoblastic B-Cell Lymphoma: A Rare Subtype of Aggressive Dural Lymphoma.
Lymphomas arising in the dura mater represent a rare subset of primary central nervous system lymphoma (PCNSL). The majority of primary dural lymphoma (PDL) are low-grade marginal zone lymphomas (MZL) characterized by an indolent course and favorable ...
Saraceni, Christine +3 more
core +1 more source
Simple Summary Pathologists working with skin biopsies of different hematological malignancies via blastic morphology need to consider a broad spectrum of diseases that, despite similar blastic features, have different outcomes and require distinct ...
Camilla Cresta +33 more
core +1 more source
A Case of Cutaneous B Lymphoblastic Lymphoma With Multiple Cutaneous Tumors
ABSTRACT A 17‐year‐old Japanese male patient was referred to our hospital due to an erythematous tumor on part of the right mandible that had developed 3 months earlier, and similar tumors had appeared on the trunk and lower extremities. A complete blood count showed no specific abnormalities.
Tomomichi Shimizu +4 more
wiley +1 more source
Results of chemotherapy by UKCCSG protocol in children with acute lymphoblastic leukemia: Clinical characteristics and outcome [PDF]
Background: Acute lymphoblastic leukemia (ALL) represents a clonal expansion and arrest of normal lymphoid hematopoiesis. ALL remains the most common malignancy in children.
پدرام, محمد +2 more
core
A 13-week Dose Intensifying Simultaneous Combination Chemotherapy (DISC) Protocol for Malignant Lymphoma in Dogs [PDF]
Das maligne Lymphom ist die häufigste hämatopoetische Neoplasie des Hundes. Die chemotherapeutische Behandlung mit Doxorubicin-haltigen Protokollen wird als die Therapie der Wahl angesehen.
Zenker, Isabella
core
T-lymphoblastic lymphoma arising in the small intestine
The authors report the clinical, pathological and immunological features of a case of T-lymphoblastic lymphoma presenting with protein-losing enteropathy. There was extensive multifocal involvement of the duodenum, jejunum and ileum.
Liang, RHS +7 more
core +1 more source
Nail Toxicities Associated With Anticancer Therapies in Children
ABSTRACT Nail toxicities are a frequent yet often underrecognized component of dermatologic adverse events in children receiving anticancer therapies. Both conventional cytotoxic chemotherapy and newer targeted agents can affect the nail matrix, nail bed and periungual tissues, producing a broad spectrum of clinical manifestations that range from ...
Luca Rapparini, Michela Starace
wiley +1 more source
ABSTRACT Ibrutinib resistance remains a major obstacle in the treatment of diffuse large B‐cell lymphoma (DLBCL). Fat mass and obesity‐associated protein (FTO) has been implicated in drug resistance through its regulation of N6‐methyladenosine (m6A) modifications; however, whether FTO mediates ibrutinib resistance in DLBCL remains unclear.
Ting‐Ting Lu +5 more
wiley +1 more source
Molecular mechanisms of follicular lymphoma and its transformation
PhDFollicular lymphoma (FL) is the second most common form of non-Hodgkin lymphoma and at least a third of cases undergo aggressive transformation (t-FL), most frequently to diffuse large B-cell lymphoma.
Wrench, David John
core

